Navigation Links
Greenway Medical Technologies' EHR and Interoperability Solution To Be Included as Part of Detroit Medical Center's Health IT Infrastructure
Date:4/6/2009

Detroit Medical Center Adds Greenway's EHR Solution to its Portfolio of Strategic Offerings for its 3,000 Affiliated Physicians

CARROLLTON, Ga., April 6 /PRNewswire/ -- Greenway Medical Technologies, a leading provider of an integrated electronic health record (EHR), practice management and interoperability solution, today announced a strategic deal with Detroit Medical Center (DMC) where physicians and care providers within the nine hospital network will have access to Greenway's flagship EHR solution, PrimeSuite(R), along with other solutions in Greenway's complete integrated physician's infrastructure.

DMC is expanding its portfolio of healthcare information technology (HIT) tools that DMC physicians can use while treating patients by adding Greenway(R) as a preferred solution to streamline clinical, financial and administrative workflows of the center's affiliated physicians and medical practices. DMC physicians, staff and other care providers selected Greenway as a preferred solution and as a part of this new relationship, DMC will be donating a percentage of the qualifying EHR technology to its affiliated physicians and medical practices under the recently modified Stark exceptions and anti-kickback safe harbors for donation of health information technology.

Along with the nine hospitals in the DMC organization, DMC also serves as the official healthcare provider of the Detroit Tigers, Detroit Red Wings, Detroit Pistons and several other professional sports franchises in the region. DMC admits more than 93,000 patients each year.

The partnership with DMC highlights Greenway's continued growth as healthcare providers begin utilizing government HIT and EHR adoption incentives to install health IT solutions that improve care, provide increased return on investment and help establish an interoperable healthcare system. These incentives (include/will soon include) financial reimburs
'/>"/>

SOURCE Greenway Medical Technologies
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Greenway Medical Technologies Continues to Champion Interoperability Efforts with Extensive Participation in HIMSS 2009 Interoperability Showcase
2. Greenway Medical Technologies Begins Offering State-of-the-Art Research Platform, PrimeResearch
3. Greenway Medical Technologies Continues Fast-Paced Growth With Addition of Cardiovascular Specialty Associates of North Texas (CSANT)
4. Greenway Medical Technologies Interoperability Engine, PrimeExchange, Allows Physicians to Securely Share Patient Data Amongst Wide Range of Providers in Patients Care Continuum
5. Greenway Medical Technologies Partners With Pediatric Associates, the Nations Largest Ambulatory Provider of General Pediatric Care
6. Greenway Medical Technologies Assists Capitol Hill With Shaping of The Presidents Stimulus Package
7. Greenway Medical Technologies and Navicure Form Partnership to Streamline Claims Management Process
8. Greenway Medical Technologies EHR Solution, PrimeSuite, Wins Three Best in KLAS Awards
9. Anthem Blue Cross and Blue Shield Foundation Awards $100,000 Grant to Shoreline Greenway Trail
10. Greenway Medical Technologies Growth Continues with Significant Fiscal Year 2008 Gains
11. Greenway Medical Technologies Leads Ambulatory Interoperability Exchange
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... This news release is available in French . ... breakthrough could revolutionize surgical practice and regenerative medicine. A ... Molle et Chimie (CNRS/ESPCI Paris Tech) and Didier Letourneur ... and Paris 13), has just demonstrated that the principle ... used in vivo to repair soft-tissue organs and tissues. ...
(Date:4/17/2014)... Scientists have identified new pain relief targets that ... pain. BBSRC-funded researchers at King,s College London made ... nerves in the periphery of the body. , ... and identifying mechanisms underlying pain generation and our ... related side effects." , One potential side effect ...
(Date:4/17/2014)... (April 17, 2014) Two recent papers by ... and colleagues may help scientists develop treatments or ... fever, Japanese encephalitis and other disease-causing flaviviruses. , ... and molecular genetics at the School of Medicine ... Hughes Medical Institute, and colleagues recently published articles ...
(Date:4/17/2014)... Il. (April 17, 2014) Doctors who treat ... called lymphangioleiomyomatosis (LAM) can face an agonizing treatment ... of the disease and help relieve shortness of ... transplants, and sirolimus can cause potentially fatal complications ... pulmonologist Dr. Daniel Dilling, medical director of Loyola ...
(Date:4/17/2014)... from Boston University School of Medicine (BUSM) have ... consumption in an experimental model. The findings, reported ... Alcohol Abuse , may lead to more effective ... is one of the leading causes of illness ... negative economic impact by limiting the productivity of ...
Breaking Medicine News(10 mins):Health News:Innovative strategy to facilitate organ repair 2Health News:Innovative strategy to facilitate organ repair 3Health News:New pain relief targets discovered 2Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2
... can do a lot to keep kids safe, experts say, , ... to be), youngsters are probably going to be spending less ... doing cannonballs. , It,s all fun and games -- until someone ... warn child safety experts. , Though many injuries amount to little ...
... Invited to Attend , , NEW ORLEANS, June 6 ... New Orleans for the 2009 Catholic Health Assembly, "In Our ... , The assembly, hosted by the Catholic Health Association of ... Catholic health care leaders from across the nation. They come ...
... ... Low Vision Conditions , ... Beach, CA (PRWEB) June 6, 2009 -- Enhanced Vision , America,s leading manufacturer of ... VISION 5K Run & Walk in Boston, MA this Saturday, June 7th. The unique event ...
... , - These acquisitions reinforce Genomma Lab,s presence in the cosmetics ... lotions and perfumes segments , , - Genomma Lab continues ... place in June 2008 , , ... C.V. (BMV: LAB) ("Genomma Lab" or "the Company"), one of ...
... study found diabetes drug didn,t increase chances of heart disease, ... drug Avandia significantly raises the risk of both heart failure ... for either cardiovascular disease or death, new research has found. ... risk of death, said the authors of the much-anticipated RECORD ...
... June 5 NxStage Medical, Inc. (Nasdaq: ... today announced it has completed the closing of its ... alliance partner, Asahi Kasei Kuraray Medical. The Company used ... its entire debt obligation, including prepayment and other transaction ...
Cached Medicine News:Health News:Summer Fun Need Not Be Hazardous 2Health News:2009 Catholic Health Assembly to Focus on Hope in a Time of Hardship and Adapting for the Future in a Time of Health Reform 2Health News:2009 Catholic Health Assembly to Focus on Hope in a Time of Hardship and Adapting for the Future in a Time of Health Reform 3Health News:Enhanced Vision Supports America's Leading Event for Blind and Visually Impaired 2Health News:Enhanced Vision Supports America's Leading Event for Blind and Visually Impaired 3Health News:Genomma Lab Internacional Acquires Brands Flor de Naranja Sanborns(MR), Teatrical and Henna Egipcia From Grupo Sanborns 2Health News:Avandia Raises Risk of Heart Failure, Fractures 2Health News:Avandia Raises Risk of Heart Failure, Fractures 3Health News:Avandia Raises Risk of Heart Failure, Fractures 4Health News:NxStage Announces Closing of $40 Million Debt Financing with Asahi Kasei Kuraray Medical 2
(Date:1/15/2014)... , Jan. 15, 2014  Humberto C. Antunes,  Galderma  ... Award" from the Journal of Drugs in Dermatology ... Clinical Conference (ODAC). The event is January 17-20, 2014, at the ... . The ODAC is a ...
(Date:1/15/2014)... Jan. 15, 2014  Manufacturers, suppliers and distributors of ... to protect their most important business assets, intellectual ... ) Because of the highly-competitive nature ... one of the most litigious industry sectors of ...
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment of ... Executive Officer.  Mark was promoted from his current role of ... four facilities in Massachusetts , ... Medical in 2012 with 20+ years of broad-based operations, sales, ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Intellectual Property Insurance for Medical-related Products and Services 2Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3
... Shire plc (LSE: SHP, Nasdaq: SHPGY ), ... its long-term extension to its open label Phase I/II study ... therapy for patients with type 1 Gaucher disease.  The data ... Gaucher Disease (EWGGD) in Cologne, Germany , and add ...
... July 1 Sagent Pharmaceuticals, Inc., a privately ... Food and Drug Administration (FDA) has approved the Company,s ... a vital anticoagulant, preventing the formation of clots and ... in surgical and dialysis settings.  According to IMS, 2009 ...
Cached Medicine Technology:Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months 2Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months 3Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months 4Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months 5Data Presented at the European Working Group on Gaucher Disease Demonstrate Continuous Improvements in Bone Mineral Density for VPRIV(R) (Velaglucerase Alfa) Through 69 Months 6FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 2FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 3FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP 4
... a sterile, nonpyrogenic, viscoelastic preparation of ... weight fraction of sodium hyaluronate., ,Healon ... dissolved in physiological sodium chloride phosphate ... weight polymer is made up of ...
... System is designed to give two viscoelastic ... be used differently and sequentially to perform ... choice of the viscoelastic is based upon ... each to facilitate performance of the surgical ...
... During fiscal year 2004, Biomet ... Navigation System to the global market, ... procedures. The Acumen technology was developed ... private company based in Hollywood, Florida. ...
... in awhile, a product comes along that ... in its category. The new StealthStation TREON ... a product. Built on the phenomenal success ... surgical navigation system in the worldthe new ...
Medicine Products: